Impact of intraoperative red blood cell salvage on transfusion requirements and outcomes in radical prostatectomy

Abstract

Perioperative CS can effectively replace PAD for RP patients, offering similar avoidance of allogeneic transfusion, with greater convenience and superior postoperative Hb levels.

Oncologic outcomes following radical prostatectomy with intraoperative cell salvage

“…The estimated 5-year risk of BCR was 15% for the IOCS group versus 18% for the group who did not receive salvaged blood. In 2009, MacIvor et al [19] reported results consistent with these earlier works at a follow-up of 24.8 months.…”

Are we ready for the use of intraoperative salvaged blood in metastatic spine tumour surgery?

“…No adverse effects were detected in the patients who received salvaged blood and there was no significant difference in the survival rates between IOCS and non-IOCS groups [15,19,31,35]. The patients receiving IOCS were found to be at least equal or superior in terms of biochemical or pathological recurrence when compared to non-IOCS groups [15,19,30,32].…”

“…advanced cellular evidence study, surgical oncologists in some other specialities were bold enough to proceed to clinical studies. They transfused salvaged blood in patients undergoing gynaecological [13,28,29] and urological cancer surgeries [14,15,19,20,[30][31][32][33]. All these studies showed that reinfusion of salvaged blood could reduce ABT requirements while the clinical outcomes of the patients who received salvaged blood were the same as those who did not [13,17,33,34].…”

Blood utilization: fostering an effective hospital transfusion culture

“…Patient demand and concerns about blood safety account for PAD's earlier popularity, but it is cost-ineffective and its use has declined since the mid-1990s [41]. For every two units of autologous blood donated, on average, only one unit is actually transfused and the other is usually wasted [42,43]. The patient may still receive allogeneic blood and, because of possible clerical errors, bacterial contamination, and prolonged storage, PAD carries many of the same risks as allogeneic transfusion.…”